These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Combined inhaled corticosteroid and long-acting beta-2-agonist in one inhaler in the treatment of chronic obstructive pulmonary disease]. Pedersen ST Ugeskr Laeger; 2005 Jun; 167(23):2504-6. PubMed ID: 16008004 [No Abstract] [Full Text] [Related]
5. Beta agonist use during asthma exacerbations: how much is too much? Patel M; Perrin K; Beasley R N Z Med J; 2011 Apr; 124(1332):77-80. PubMed ID: 21747427 [TBL] [Abstract][Full Text] [Related]
7. [Are there any advantages of a fixed combination in the treatment of asthma with respect to safety and tolerability?]. Virchow C Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S376-80. PubMed ID: 19941240 [No Abstract] [Full Text] [Related]
8. [Asthma and COPD: guidance in the jungle of inhalative drugs]. Hering T MMW Fortschr Med; 2015 May; 157(10):59, 61-2. PubMed ID: 26019099 [No Abstract] [Full Text] [Related]
9. Inhaled corticosteroid therapy in asthma: a balancing act. Li JT Ann Allergy Asthma Immunol; 1999 Mar; 82(3):229-30. PubMed ID: 10094213 [No Abstract] [Full Text] [Related]
10. Interactions between corticosteroids and beta2-agonists in asthma and chronic obstructive pulmonary disease. Johnson M Proc Am Thorac Soc; 2004; 1(3):200-6. PubMed ID: 16113435 [TBL] [Abstract][Full Text] [Related]
11. [Clinical effectiveness of synergic therapy]. Płusa T; Lubiński W Pol Merkur Lekarski; 2004 May; 16 Suppl 1():20-2. PubMed ID: 15524008 [TBL] [Abstract][Full Text] [Related]
12. [Inhalation steroids in COPD: of value only for asthma patients!]. Hien M MMW Fortschr Med; 2003 Oct; 145(44):16. PubMed ID: 14655500 [No Abstract] [Full Text] [Related]
13. Triple inhalers for obstructive airways disease: will they be useful? Barnes PJ Expert Rev Respir Med; 2011 Jun; 5(3):297-300. PubMed ID: 21702649 [No Abstract] [Full Text] [Related]
14. Long-acting beta-agonists in asthma. Agarwal A N Engl J Med; 2009 Jul; 361(2):208; author reply 209. PubMed ID: 19587350 [No Abstract] [Full Text] [Related]
15. Formoterol (Perforomist) for COPD. Med Lett Drugs Ther; 2007 Nov; 49(1274):94-5. PubMed ID: 18007544 [No Abstract] [Full Text] [Related]
16. [Do fixed ICS/LABA-combinations have advantages in terms of patient-centered parameters?]. Buhl R Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S381-5. PubMed ID: 19941241 [No Abstract] [Full Text] [Related]
17. Combination therapy with maintenance budesonide and formoterol in COPD. Medford AR Eur Respir J; 2004 Dec; 24(6):1070; author reply 1070-1. PubMed ID: 15572556 [No Abstract] [Full Text] [Related]
18. Clinical Inquiry: what are the benefits and risks of inhaled corticosteroids for COPD? Hamilton T; Miller JB; Vincent EC; St Anna L J Fam Pract; 2014 May; 63(5):276-8. PubMed ID: 24795909 [No Abstract] [Full Text] [Related]
19. A pragmatic approach to simplify inhaler therapy for COPD. Lipworth B; Jabbal S Lancet Respir Med; 2017 Sep; 5(9):679-681. PubMed ID: 28693987 [No Abstract] [Full Text] [Related]
20. Achieving therapeutic benefits of inhaled corticosteroids/beta2 agonist in chronic obstructive airway disease. Wang ZL Chin Med J (Engl); 2007 Jun; 120(12):1097-105. PubMed ID: 17637229 [No Abstract] [Full Text] [Related] [Next] [New Search]